• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增殖性糖尿病视网膜病变的光凝治疗:不良治疗效果与视网膜病变严重程度的关系。糖尿病视网膜病变研究报告第5号。

Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5.

出版信息

Dev Ophthalmol. 1981;2:248-61.

PMID:7262408
Abstract

Xenon are photocoagulation, as carried out in the DRS, is attended by an increased risk of serious macular damage secondary to vitreoretinal traction. This risk is of particular importance in eyes with severe fibrous proliferations and/or localized traction retinal detachment. Little evidence was found of such an effect following argon laser photocoagulation, although some, mostly less serious, visual acuity decreases were attributable to this treatment as well. After 4 years of follow-up, the beneficial effect of xenon photocoagulation in reducing the risk of severe visual loss outweighed its harmful effect, even in eyes with severe fibrous proliferations and/or traction retinal detachment. A beneficial effect of approximately equal magnitude was present in the argon group.

摘要

氙光凝术(如在糖尿病性视网膜病变研究中所进行的)会因玻璃体视网膜牵拉而导致严重黄斑损伤的风险增加。这种风险在伴有严重纤维增生和/或局限性牵拉性视网膜脱离的眼中尤为重要。尽管氩激光光凝术后也有一些(大多不太严重)视力下降可归因于该治疗,但几乎没有证据表明氩激光光凝会产生这样的影响。经过4年的随访,即使在伴有严重纤维增生和/或牵拉性视网膜脱离的眼中,氙光凝术在降低严重视力丧失风险方面的有益作用也超过了其有害作用。氩激光组也存在大致相同程度的有益作用。

相似文献

1
Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5.增殖性糖尿病视网膜病变的光凝治疗:不良治疗效果与视网膜病变严重程度的关系。糖尿病视网膜病变研究报告第5号。
Dev Ophthalmol. 1981;2:248-61.
2
Xenon arc photocoagulation of proliferative diabetic retinopathy (a review of 2688 consecutive eyes in the format of the diabetic retinopathy study--DRS).增殖性糖尿病视网膜病变的氙弧光凝术(以糖尿病视网膜病变研究——DRS的形式对2688只连续眼进行的回顾)
Trans Am Ophthalmol Soc. 1983;81:229-45.
3
Photocoagulation in diabetic retinopathy. A multicentre study in Sweden.糖尿病性视网膜病变的光凝治疗。瑞典的一项多中心研究。
Acta Ophthalmol Suppl. 1984;162:1-100.
4
[Effect of argon laser photocoagulation on diabetic retinopathy].[氩激光光凝术对糖尿病视网膜病变的影响]
Di Yi Jun Yi Da Xue Xue Bao. 2004 Nov;24(11):1313-5.
5
The diabetic retinopathy study and the early treatment diabetic retinopathy study.糖尿病视网膜病变研究和糖尿病视网膜病变早期治疗研究。
Int Ophthalmol Clin. 1984 Winter;24(4):13-29.
6
Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings.增殖性糖尿病视网膜病变的光凝治疗:糖尿病视网膜病变研究结果的第二篇报告
Ophthalmology. 1978 Jan;85(1):82-106. doi: 10.1016/s0161-6420(78)35693-1.
7
[Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].[2型糖尿病并发症糖尿病性视网膜病变患者的激光光凝治疗结果]
Klin Oczna. 2006;108(1-3):66-9.
8
[Comparative use of diode and argon laser for panretinal photocoagulation in diabetic retinopathy].[二极管激光与氩激光在糖尿病性视网膜病变全视网膜光凝中的对比应用]
Ophthalmologe. 1993 Oct;90(5):457-62.
9
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.后Tenon囊下注射曲安奈德可预防严重糖尿病视网膜病变且视力良好患者的全视网膜光凝所致视觉功能障碍。
Ophthalmology. 2006 Mar;113(3):381-7. doi: 10.1016/j.ophtha.2005.10.035. Epub 2006 Feb 3.
10
[A grid pattern type of photocoagulation in treatment of diabetic maculopathy--personal experience].[格栅样光凝治疗糖尿病性黄斑病变——个人经验]
Klin Oczna. 2000;102(3):183-6.

引用本文的文献

1
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制。
Cochrane Database Syst Rev. 2023 Mar 28;3(3):CD006127. doi: 10.1002/14651858.CD006127.pub3.
2
Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.抗血管内皮生长因子治疗增生型糖尿病视网膜病变。
Cochrane Database Syst Rev. 2023 Mar 20;3(3):CD008721. doi: 10.1002/14651858.CD008721.pub3.
3
Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy.口服抗氧化剂补充剂在糖尿病视网膜病变治疗中的作用。
Int J Mol Sci. 2021 Apr 13;22(8):4020. doi: 10.3390/ijms22084020.
4
Long-Term Visual Function Effects of Pan-Retinal Photocoagulation in Diabetic Retinopathy and Its Impact in Real Life.全视网膜光凝治疗糖尿病视网膜病变的长期视觉功能影响及其在现实生活中的作用
Diabetes Metab Syndr Obes. 2021 Mar 19;14:1281-1293. doi: 10.2147/DMSO.S301747. eCollection 2021.
5
Patient-Reported Outcomes Reveal Impairments Not Explained by Psychophysical Testing in Patients With Regressed PDR.患者报告结局揭示了视网膜病变退化的增殖性糖尿病视网膜病变患者中,心理物理学测试无法解释的损伤情况。
Transl Vis Sci Technol. 2019 Jul 29;8(4):11. doi: 10.1167/tvst.8.4.11. eCollection 2019 Jul.
6
An optical coherence tomography study of residual subfoveal fluid after successful pars plana vitrectomy in patients with diabetic tractional macular detachment.光学相干断层扫描研究糖尿病牵引性黄斑脱离患者经成功的巩膜扣带手术后残留的中心凹下液。
Eye (Lond). 2018 Sep;32(9):1472-1477. doi: 10.1038/s41433-018-0111-6. Epub 2018 May 23.
7
Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.用于糖尿病视网膜病变的血管内皮生长因子抑制剂
Curr Diab Rep. 2016 Dec;16(12):122. doi: 10.1007/s11892-016-0825-4.
8
System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation.英国伦敦萨顿和默顿地区糖尿病视网膜病变筛查未就诊情况的系统层面及患者层面解释:一项服务评估的定性分析
BMJ Open. 2016 May 18;6(5):e010952. doi: 10.1136/bmjopen-2015-010952.
9
Blood pressure control for diabetic retinopathy.糖尿病视网膜病变的血压控制
Cochrane Database Syst Rev. 2015 Jan 31;1:CD006127. doi: 10.1002/14651858.CD006127.pub2.
10
Retinal Nerve Fiber Layer Alterations After Photocoagulation: A Prospective Spectral-Domain OCT Study.光凝术后视网膜神经纤维层改变:一项前瞻性光谱域光学相干断层扫描研究
Open Ophthalmol J. 2014 Nov 28;8:82-6. doi: 10.2174/1874364101408010082. eCollection 2014.